Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and first half (H1) of the fiscal year 2024-2025. The company’s consolidated revenue for Q2 rose by 17% year-on-year (YoY) to ₹2,242 crore, supported by significant demand in its contract development and manufacturing organization (CDMO) business. Piramal also […]
Piramal Pharma Limited’s Consumer Products Division (CPD) has announced its entry into the men’s personal grooming sector, launching the BOHEM product range. This innovative lineup, inspired by the Bohemian ethos of uniqueness and an unconventional lifestyle, includes a Hair Removal Spray, Beard Growth Oil, and Underarm Roll-On. Through BOHEM, Piramal Pharma aims to transform male […]
